Evidence map›Paper›PMID 29599934›Full record

ReviewOncotarget2018

Liquid biopsy provides new insights into gastric cancer.

Camila Tavares Uchôa Guimarães, Nina Nayara Ferreira Martins, Kelly Cristina da Silva Oliveira, Caroline Martins Almeida, Thayanne Macedo Pinheiro, Carolina Oliveira Gigek, Sandro Roberto de Araújo Cavallero, Paulo Pimentel Assumpção, Marília Arruda Cardoso Smith, Rommel Rodríguez Burbano and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. The Emerging Role of Liquid Biopsy in Gastric Cancer.Journal of clinical medicine · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Camila Tavares Uchôa GuimarãesResidência Multiprofissional em Oncologia, Hospital Universitário João de Barros Barreto, Universidade Federal do Pará, Belém, PA, Brazil.
Nina Nayara Ferreira MartinsNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil.
Kelly Cristina da Silva OliveiraNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil.
Caroline Martins AlmeidaResidência Multiprofissional em Oncologia, Hospital Universitário João de Barros Barreto, Universidade Federal do Pará, Belém, PA, Brazil.
Thayanne Macedo PinheiroNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil.
Carolina Oliveira GigekDisciplina de Genética, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Sandro Roberto de Araújo CavalleroNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil.
Paulo Pimentel AssumpçãoNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil.
Marília Arruda Cardoso SmithDisciplina de Genética, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Rommel Rodríguez BurbanoNúcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil.
Danielle Queiroz CalcagnoResidência Multiprofissional em Oncologia, Hospital Universitário João de Barros Barreto, Universidade Federal do Pará, Belém, PA, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liquid biopsies have great promise for precision medicine as they provide information about primary and metastatic tumors via a minimally invasive method. In gastric cancer patients, a large number of blood-based biomarkers have been reported for their potential role in clinical practice for screening, early diagnosis, prognostic evaluation, recurrence monitoring and therapeutic efficiency follow-up. This current review focuses on blood liquid biopsies' role and their clinical implications in gastric cancer patients, with an emphasis on circulating tumor cells (CTCs), circulating tumor DNA (ctDNA) and circulating non-coding RNAs (ncRNAs). We also provide a brief discussion of the potential and limitations of liquid biopsies use and their future use in the routine clinical care of gastric cancer.

Indexed as

circulating long non-coding RNAscirculating microRNAscirculating tumor cellscirculating tumor DNAprecision medicine

Identifiers

PMID29599934
PMCPMC5871105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.